301 OMX-0407, a highly potent SIK3 inhibitor, sensitizes tumor cells to apoptosis and eradicates tumors in combination with PD-1 inhibition

Bibliographic Details
Main Authors: Christina Hartl, Tillmann Michels, Ronny Milde, Vanessa Klein, Philipp Beckhove, Hannes Loferer, Stefan Bissinger
Format: Article
Language:English
Published: BMJ Publishing Group 2021-11-01
Series:Journal for ImmunoTherapy of Cancer
_version_ 1830507963420246016
author Christina Hartl
Tillmann Michels
Ronny Milde
Vanessa Klein
Philipp Beckhove
Hannes Loferer
Stefan Bissinger
author_facet Christina Hartl
Tillmann Michels
Ronny Milde
Vanessa Klein
Philipp Beckhove
Hannes Loferer
Stefan Bissinger
author_sort Christina Hartl
collection DOAJ
first_indexed 2024-12-22T01:13:15Z
format Article
id doaj.art-423953da805c440f99710906966560cd
institution Directory Open Access Journal
issn 2051-1426
language English
last_indexed 2024-12-22T01:13:15Z
publishDate 2021-11-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj.art-423953da805c440f99710906966560cd2022-12-21T18:43:55ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262021-11-019Suppl 210.1136/jitc-2021-SITC2021.301301 OMX-0407, a highly potent SIK3 inhibitor, sensitizes tumor cells to apoptosis and eradicates tumors in combination with PD-1 inhibitionChristina Hartl0Tillmann Michels1Ronny Milde2Vanessa Klein3Philipp Beckhove4Hannes Loferer5Stefan Bissinger61Dana Farber Cancer Institute, Boston, MA, USA1iOmx Therapeutics AG, Martinsried/Munich, Germany1iOmx Therapeutics AG, Martinsried/Munich, Germany1iOmx Therapeutics AG, Martinsried/Munich, Germany2RCI Center for Interventional Immunology, Regensburg, Germany1iOmx Therapeutics AG, Martinsried/Munich, Germany1iOmx Therapeutics AG, Martinsried/Munich, Germany
spellingShingle Christina Hartl
Tillmann Michels
Ronny Milde
Vanessa Klein
Philipp Beckhove
Hannes Loferer
Stefan Bissinger
301 OMX-0407, a highly potent SIK3 inhibitor, sensitizes tumor cells to apoptosis and eradicates tumors in combination with PD-1 inhibition
Journal for ImmunoTherapy of Cancer
title 301 OMX-0407, a highly potent SIK3 inhibitor, sensitizes tumor cells to apoptosis and eradicates tumors in combination with PD-1 inhibition
title_full 301 OMX-0407, a highly potent SIK3 inhibitor, sensitizes tumor cells to apoptosis and eradicates tumors in combination with PD-1 inhibition
title_fullStr 301 OMX-0407, a highly potent SIK3 inhibitor, sensitizes tumor cells to apoptosis and eradicates tumors in combination with PD-1 inhibition
title_full_unstemmed 301 OMX-0407, a highly potent SIK3 inhibitor, sensitizes tumor cells to apoptosis and eradicates tumors in combination with PD-1 inhibition
title_short 301 OMX-0407, a highly potent SIK3 inhibitor, sensitizes tumor cells to apoptosis and eradicates tumors in combination with PD-1 inhibition
title_sort 301 omx 0407 a highly potent sik3 inhibitor sensitizes tumor cells to apoptosis and eradicates tumors in combination with pd 1 inhibition
work_keys_str_mv AT christinahartl 301omx0407ahighlypotentsik3inhibitorsensitizestumorcellstoapoptosisanderadicatestumorsincombinationwithpd1inhibition
AT tillmannmichels 301omx0407ahighlypotentsik3inhibitorsensitizestumorcellstoapoptosisanderadicatestumorsincombinationwithpd1inhibition
AT ronnymilde 301omx0407ahighlypotentsik3inhibitorsensitizestumorcellstoapoptosisanderadicatestumorsincombinationwithpd1inhibition
AT vanessaklein 301omx0407ahighlypotentsik3inhibitorsensitizestumorcellstoapoptosisanderadicatestumorsincombinationwithpd1inhibition
AT philippbeckhove 301omx0407ahighlypotentsik3inhibitorsensitizestumorcellstoapoptosisanderadicatestumorsincombinationwithpd1inhibition
AT hannesloferer 301omx0407ahighlypotentsik3inhibitorsensitizestumorcellstoapoptosisanderadicatestumorsincombinationwithpd1inhibition
AT stefanbissinger 301omx0407ahighlypotentsik3inhibitorsensitizestumorcellstoapoptosisanderadicatestumorsincombinationwithpd1inhibition